Investors hammered Merck stock Tuesday after the company beat fourth-quarter expectations, but delivered a light 2025 outlook.
We recently published a list of 12 Best Dow Stocks to Buy Right Now. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other best dow stocks to buy ...
Merck's move for Sigma-Aldrich is the latest in a series of major merger and acquisition moves in the pharma sector, but creates a new company to serve the global pharma industry, rather than a ...
Now that the year is underway and a new presidential administration is in place in Washington, let’s consider the environment ...
While Merck has traditionally relied more on its internal R&D capabilities than mergers and acquisitions to grow its business, new chief executive Robert Davis said earlier this year that approach ...
In yet another merger between two major pharmaceutical companies, Merck will acquire Schering-Plough for $41.1 billion, the two companies linkurl:announced;http://www ...
President-elect Trump's return to the White House could bring an uptick in mergers and acquisitions, as markets anticipate tax and regulatory reforms that will boost dealmaking. Royal Palm ...
In addition, mergers among biotechs have long ... for $1.3 billion in October 2003 and Merck's (Whitehouse Station, NJ, USA) acquisition of Sirna (San Francisco) for $1.1 billion late in 2006.
Merck & Co Inc on Thursday reported steady top-line growth, though profit took a hit due to the cost of recent acquis ... Subscribe now to see this Premium News article from Alliance News ...
In this article, we are going to take a look at where Merck & Co., Inc. (NYSE ... Lower interest rates have also eased capital costs, contributing to increased mergers and acquisitions activity.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results